Evidence map›Paper›PMID 42897482›Full record

ArticleBMC gastroenterology2026

Coordinated upregulation of Hippo, NF-κB and interferon pathway genes in pancreatic ductal adenocarcinoma: a retrospective tissue qRT-PCR profiling study with external tumour-versus-non-tumour validation, molecular subtype and survival analyses.

Eda Balkan, Murat Kızılkaya, Sevilay Özmen, Necip Altundaş, Mert Yüksel, Mahmut Aktürk, Abdulkadir Aktepe, Nurhak Aksungur

Abstract read
In one paragraph

Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eda BalkanDepartment of Medical Biology, Faculty of Medicine, Atatürk University, Erzurum, Türkiye. edadiyarbakir@atauni.edu.tr.
Murat KızılkayaDepartment of Medical Biology, Faculty of Medicine, Ağrı İbrahim Çeçen University, Ağrı, Türkiye.
Sevilay ÖzmenDepartment of Pathology, Faculty of Medicine, Atatürk University, Erzurum, Türkiye.
Necip AltundaşDepartment of General Surgery, Faculty of Medicine, Atatürk University, Erzurum, Türkiye.
Mert YükselSchool of Medicine, Faculty of Medicine, Atatürk University, Erzurum, Türkiye.
Mahmut AktürkDepartment of Medical Biology, Faculty of Medicine, Atatürk University, Erzurum, Türkiye.
Abdulkadir AktepeDepartment of General Surgery, Faculty of Medicine, Atatürk University, Erzurum, Türkiye.
Nurhak AksungurDepartment of General Surgery, Faculty of Medicine, Atatürk University, Erzurum, Türkiye.

Funding

Atatürk Üniversitesi 2025
6 · The paper itself

Abstract

objectivesPancreatic ductal adenocarcinoma (PDAC) is one of the most lethal solid tumours. Alterations in Hippo, NF-κB and interferon (IFN)-related signalling have each been implicated in its biology, but the extent to which these transcriptional programmes are coordinately dysregulated in tumour tissue remains incompletely defined. This study therefore set out to determine whether these programmes are coordinately upregulated in PDAC tissue, and whether individual transcripts discriminate tumour from non-tumour tissue reproducibly in an independent cohort.

methodsIn this retrospective study we profiled 17 mRNA targets by real-time quantitative PCR in 50 formalin-fixed paraffin-embedded PDAC specimens and 35 non-tumoural pancreatic tissue samples, covering the Hippo pathway core and output, the inflammation/IL-6 module, the IFN-related axis and the NF-κB cascade, normalised to GAPDH using the 2 - ΔΔCt method. Discrimination was assessed by full-cohort receiver-operating-characteristic analysis without resampling and by nested cross-validation, and associations with clinicopathological variables were tested with Benjamini-Hochberg correction. Findings were evaluated externally in GSE62452 and TCGA-PAAD.

resultsAll 17 transcripts were significantly upregulated in PDAC (FDR < 0.05), with median fold-changes from 3.4 (WWTR1) to 18.4 (LATS1). MYD88, ANKRD1, ISG15 and YY1 discriminated best (AUC 0.853-0.911), and nested cross-validation gave a signature AUC of 0.890 (95% CI 0.821-0.959), only marginally better than MYD88 alone. No clinicopathological variable was associated with transcript abundance after correction. In GSE62452 (69 PDAC, 61 adjacent non-tumour tissues) eight transcripts replicated with concordant direction, led by YAP1 (AUC 0.791), TEAD1 (0.760) and MYD88 (0.755), and the fixed four-gene discovery signature retained discrimination (AUC 0.798, 95% CI 0.719-0.877). Replication was gene-specific rather than module-wide: IL6, the remaining NF-κB transcripts and four Hippo members did not replicate, and IFNB1 was discordant. Hippo output genes tracked the basal-like subtype in both external cohorts. In TCGA-PAAD, high YY1 (HR 2.01; p = 0.001) and high YAP1 (HR 1.72; p = 0.010) predicted shorter survival, but both associations lost significance when the analysis was restricted to ductal-type histology.

conclusionsPDAC tissue shows coordinated upregulation across these four modules, but only eight of the seventeen transcripts replicated externally, most strongly within the Hippo effector axis and for MYD88. YAP1, TEAD1, MYD88 and STK4 reached validation AUCs above 0.70 and are prioritised for prospective study. Because transcript abundance does not measure pathway activity and all data derive from bulk tissue, these associations are hypothesis-generating rather than mechanistic.

Indexed as

Carcinoma, Pancreatic DuctalInterferonsNF-kappa BPancreatic NeoplasmsProtein Serine-Threonine KinasesAdaptor Proteins, Signal TransducingAgedDNA-Binding ProteinsFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHippo Signaling PathwayHumansMaleMiddle AgedNuclear ProteinsAdaptor Proteins, Signal TransducingDNA-Binding ProteinsInterferonsNF-kappa BNuclear ProteinsPhosphoproteinsProtein Serine-Threonine KinasesRNA, MessengerTEAD1 protein, humanTEA Domain Transcription FactorsTranscription FactorsYAP1 protein, humanYAP-Signaling ProteinsHippo signallingInterferon receptorNF-κB/IL-6 axisPancreatic ductal adenocarcinomaTCGA-PAADTranscriptional profilingTurkish patientsYAP1

Identifiers

PMID42897482
PMCPMC13679222

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.